Characterization and inactivation of an agmatine deiminase from Helicobacter pylori
- SC
Helicobacter pylori encodes a potential virulence factor, agmatine deiminase (HpAgD), which catalyzes the conversion of agmatine to N-carbamoyl putrescine (NCP) and ammonia - agmatine is decarboxylated arginine. Agmatine is an endogenous human cell signaling molecule that triggers the innate immune response in humans. Unlike H. pylori, humans do not encode an AgD; it is hypothesized that inhibition of this enzyme would increase the levels of agmatine, and thereby enhance the innate immune response. Taken together, these facts suggest that HpAgD is a potential drug target. Herein we describe the optimized expression, isolation, and purification of HpAgD (10-30 mg/L media). The initial kinetic characterization of this enzyme has also been performed. Additionally, the crystal structure of wild-type HpAgD has been determined at 2.1 {angstrom} resolution. This structure provides a molecular basis for the preferential deimination of agmatine, and identifies Asp198 as a key residue responsible for agmatine recognition, which has been confirmed experimentally. Information gathered from these studies led to the development and characterization of a novel class of haloacetamidine-based HpAgD inactivators. These compounds are the most potent AgD inhibitors ever described.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- OSTI ID:
- 1018562
- Journal Information:
- Bioorg. Chem., Vol. 38, Issue (2) ; 04, 2010; ISSN 0045-2068
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Helicobacter pylori flagellin: TLR5 evasion and fusion-based conversion into a TLR5 agonist
Enzyme-ligand interactions that drive active site rearrangements in the Helicobacter pylori 5ยด-methylthioadenosine/S-adenosylhomocysteine nucleosidase